Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Thrombocythemia, Essential 1Polycythemia Vera 1

Interventions

ruxolitinib 3venetoclax 1veliparib 1pevonedistat 1navitoclax 1givinostat hydrochloride 1givinostat 1fludarabine phosphate 1bomedemstat 1anagrelide 1Whole-Body Irradiation 1Valganciclovir 1Topotecan 1Therapeutics 1Tacrolimus 1Sirolimus 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Melphalan 1INCB057643 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Etoposide 1Drug Evaluation 1Cyclosporine 1Cyclophosphamide 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Thrombocythemia, Essential × bomedemstat × Clear all
NCT04262141 2026-01-07

IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)

University of Miami

Phase 2 Active not recruiting
4 enrolled
Myeloid

Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon âš¡